Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.33 |
| ▸ | CTSD | P07339 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 3/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.32 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.32 |
| ▸ | CDK9 | P50750 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.32 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.32 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.32 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | HTR2B | P41595 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | IDO1 | P14902 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4763821 | 0.74 | — | — | |
| SCHEMBL7933831 | 0.70 | MAPT (0.55) | ALDH1A1HSD17B10SMN1; SMN2MAPK1 | |
| SCHEMBL8973418 | 0.69 | — | — | |
| SCHEMBL4724746 | 0.69 | TDP1 (0.31) | TDP1 | |
| SCHEMBL4722775 | 0.69 | — | — | |
| SCHEMBL2423602 | 0.69 | — | — | |
| SCHEMBL819437 | 0.69 | MAPT (0.32) | HSD17B10SMN1; SMN2 | |
| SCHEMBL440187 | 0.67 | — | — | |
| SCHEMBL311562 | 0.67 | HSD17B10 (0.50) | TDP1ALDH1A1HSD17B10CTSDTSHR | |
| SCHEMBL237661 | 0.67 | HPGD (0.38) | ALDH1A1HSD17B10SMN1; SMN2MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 221 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118324816-A | Organometallic compound, light-emitting device, electronic apparatus, and electronic device | 三星显示有限公司 | 2024-07-12 | — | — | CN | claimed |
| US-11991925-B2 | Light-emitting device including condensed cyclic compound and electronic apparatus including the light-emitting device | SAMSUNG DISPLAY CO., LTD. (KR) | 2024-05-21 | — | — | US | claimed |
| CN-117135987-A | Organometallic compound, light-emitting device including the same, electronic device, and electronic device | 三星显示有限公司 | 2023-11-28 | — | — | CN | claimed |
| CN-117062455-A | Organic light emitting device and electronic apparatus including the same | 三星显示有限公司 | 2023-11-14 | — | — | CN | claimed |
| CN-116896914-A | Organometallic compound, light-emitting device including the same, electronic device, and electronic device | 三星显示有限公司 | 2023-10-17 | — | — | CN | claimed |
| CN-116640169-A | Organometallic compound, light-emitting device, and electronic device | 三星显示有限公司 | 2023-08-25 | — | — | CN | claimed |
| CN-116583161-A | Light emitting device and electronic apparatus including the same | 三星显示有限公司 | 2023-08-11 | — | — | CN | claimed |
| CN-116507146-A | Heterocyclic compound, light-emitting device including the same, and electronic apparatus | 三星显示有限公司 | 2023-07-28 | — | — | CN | claimed |
| CN-116437783-A | Organometallic compound, light-emitting device, and electronic device | 三星显示有限公司 | 2023-07-14 | — | — | CN | claimed |
| CN-116265472-A | Heterocyclic compound, light-emitting device including the same, and electronic apparatus | 三星显示有限公司 | 2023-06-20 | — | — | CN | claimed |
| WO-2013119542-A1 | COMPOUNDS FOR THE TREATMENT OF HEPATITIS C | BRISTOL-MYERS SQUIBB COMPANY (US) | 2013-08-15 | — | — | WO | claimed |
| US-20130203758-A1 | Compounds for the Treatment of Hepatitis C | BRISTOL-MYERS SQUIBB COMPANY (US) | 2013-08-08 | — | — | US | claimed |
| US-8324217-B2 | Cold menthol receptor antagonists | JANSSEN PHARMACEUTICA NV (BE) | 2012-12-04 | — | — | US | claimed |
| US-20120136006-A1 | COLD MENTHOL RECEPTOR ANTAGONISTS | COLBURN RAYMOND W (US) | 2012-05-31 | — | — | US | claimed |
| US-8143259-B2 | Cold menthol receptor antagonists | JANSSEN PHARMACEUTICA, NV (BE) | 2012-03-27 | — | — | US | claimed |
| JP-2012500267-A | — | — | 2012-01-05 | — | — | JP | claimed |
| EP-2331499-A1 | COLD MENTHOL RECEPTOR ANTAGONISTS | Janssen Pharmaceutica, N.V. (BE) | 2011-06-15 | — | — | EP | claimed |
| WO-2010021878-A1 | COLD MENTHOL RECEPTOR ANTAGONISTS | JANSSEN PHARMACEUTICA NV (BE) | 2010-02-25 | — | — | WO | claimed |
| US-20100048589-A1 | Cold Menthol Receptor Antagonists | JANSSEN PHARMACEUTICA NV (BE) | 2010-02-25 | — | — | US | claimed |
| US-20080220286-A1 | Electroluminescent compound; high color purity, high fluorescence yield, and high electric luminance yield; easy to synthesize and can easily form films | TSINGHUA UNIVERSITY (CN) | 2008-09-11 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100048589-A1 | Cold Menthol Receptor Antagonists | TRPV1, TRPM2, TRPM6 | TDP1 4132/4885ALDH1A1 1175/4885HSD17B10 2232/4885 |
| US-20130203758-A1 | Compounds for the Treatment of Hepatitis C | HAVCR2, SLC10A1, HCCS | TDP1 3844/4885ALDH1A1 253/4885HSD17B10 638/4885 |
| US-20120136006-A1 | COLD MENTHOL RECEPTOR ANTAGONISTS | TRPV1, TRPM2, TRPM6 | TDP1 4132/4885ALDH1A1 1175/4885HSD17B10 2232/4885 |
| US-20080220286-A1 | Electroluminescent compound; high color purity, high fluorescence yield, and high electric luminance yield; easy to synthesize and can easily form films | EED, DDT, RABL6 | TDP1 1015/4885ALDH1A1 811/4885HSD17B10 4113/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.